Leflunomide as adjunct therapy for BK viremia management in pediatric kidney transplant recipients

Background BK viremia after kidney transplantation (KT) poses significant risk for BK virus‐associated nephropathy and impacts graft survival. Conventional treatment involves reduction of immunosuppression, which in turn may increase risk for rejection. To address this dilemma, use of anti‐viral the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric transplantation 2024-03, Vol.28 (2), p.e14724-n/a
Hauptverfasser:	Aldieri, Alexandra, Chandran, Mary, Matossian, Debora, Hariprasad, Aparna, Magella, Bliss, Lazear, Danielle, Blanchette, Eliza, Benz, Eric, Bock, Margret
Format:	Artikel
Sprache:	eng
Schlagworte:	Biopsy Calcineurin inhibitors Dosage Eradication Graft rejection Immunosuppression Immunosuppressive agents Kidney transplantation Leflunomide Mycophenolic acid Nephropathy Patients pediatric kidney transplant Pediatrics Regression analysis Transplants & implants Viremia virus Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!